Topics

Companies Related to "Novartis Reports Positive Results From Ofatumumab Phase Studies" [Most Relevant Company Matches] RSS

12:22 EST 13th November 2019 | BioPortfolio

Here are the most relevant search results for "Novartis Reports Positive Results From Ofatumumab Phase Studies" found in our extensive corporate database of over 50,000 company records.

Showing "Novartis Reports Positive Results From Ofatumumab Phase Studies" Companies 1–25 of 3,500+

Relevant

Cadent Therapeutics

Cadent Therapeutics is creating breakthrough therapies for the treatment of movement disorders and cognitive impairment. The company combines target specificity, patient selection, drug design and optimization, and novel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders. Cadent Therapeutics is rapidly advan...


Calvert Laboratories, Inc.

We excel in the design and submission of preclinical development programs to various regulatory agencies (FDA, EPA, EEC, OECD, MHW) located all over the world. We are experienced in virtually all classes of compounds. We offer capabilities in the performance of studies to support the safety evaluation of drugs, chemicals and some devices from not only the discovery phase but through the preclinica...

AFFiRiS AG

On the basis of the company's own patents, AFFiRiS develops tailor-made peptide vaccines against Alzheimer's disease, atherosclerosis, Parkinson's disease hypertension and four other conditions with an urgent medical requirement and attractive market volumes. Alzheimer's is currently the most advanced project, with two potential products having just completed the phase I clinical studies. In O...


CMAXA division of
Institute of Drug Technology (IDT) Australia Ltd

CMAX’s clinical research and analytical facility is committed to providing excellence and quality when servicing the needs of pharmaceutical manufacturers and researchers worldwide. CMAX is located in Adelaide, South Australia, and offers a wide range of services for the design, implementation and management of Phase I - IV clinical studies.The self contained clinical unit has a 48 bed capacity ...

Novartis Consumer Health

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in each of these areas. In ...

Allied Research International Inc

Allied Research International Inc. (formerly known as Allied Clinical Research) is a dynamic group of scientific and medical professionals dedicated to the advancement of clinical research. For over ten years, Allied Research International (ARI) has been providing services to Pharmaceutical and Biotechnology industries. These services range from conducting complex single site Phase I / Bioequivale...

BioCor

Through extensive interactions with the FDA, EMEA, and local European regulatory agencies during IND, end-of-phase II, and pre-NDA meetings we have acquired extensive knowledge in many therapeutic areas and have supported many clients to receive regulatory approval for their products.Over the last five years we have successfully completed over 150 studies covering all phases of drug development. A...

Vicus Therapeutics, LLC

Vicus Therapeutics is a biopharmaceutical company dedicated to bringing breakthrough therapies to patients with cancer. Vicus' lead investigational therapy, VT-122, is a combination of etodolac and propranolol. VT-122 showed positive results in a Phase 2 clinical trial of lung cancer patients and is currently being evaluated in a Phase 2 clinical trial of liver cancer patients receiving Nexavar ...

OPTIMED Clinical Research

OPTIMED Clinical Research is an independent company, which offers its experience for phase I to phase IV studies and surveys.Located in Grenoble, France since 1990, OPTIMED Clinical Research has led numerous clinical studies on behalf of the pharmaceutical and agro-food industry.Making your constraints its own, OPTIMED Clinical Research has set up an efficient organization for your studies : adher...

Pinnacle Research Group LLC

Pinnacle Research Group, a multi-specialty clinical trials organization, conducts Phase I - IV clinical drug and device studies over a broad therapeutic area. Our facilities include inpatient capabilities with sleeping, food preparation, diagnostics, and medical emergency capabilities. Our site has been subjected to review and audit by organizations including Institutional Review Boards (2), Spons...

Direct Therapeutics, Inc.

Direct Therapeutics, Inc. is a development-stage pharmaceutical company using its patented Solvent-Facilitated Perfusion technology to create new drugs for the localized and regional treatment of solid-tumor cancers. Our products are designed for direct injection to target tissue with minimal invasion of healthy tissue. They contain active ingredients in organic solvent vehicles that facilitate th...

Drug Development Solutions Limited

Drug Development Solutions (DDS, formerly DDS Medicines Research) is one of the oldest UK-based Contract Research Organisations. We are independently owned and specialise in Phase I clinical trials, especially in First-In-Man and Phototoxicity studies. In more than 23 years, DDS has performed over 690 research studies, covering a wide range of pharmacokinetic and pharmacodynamic studies in all the...

MAC Clinical Research

MAC is the largest Clinical Development Organisation (CDO) in Europe conducting studies from Phase I-IV for sponsors at MAC owned facilities which include MAC’s 42 bed Early Phase Unit in Manchester, England, which gained MHRA accreditation in 2016 where First Time In Man /First Time In Patient studies are conducted; MAC’s state of the art Sleep ...

Northwest Kinetics Incorporated

Northwest Kinetics is an independent research facility which specializes in Phase I and Phase II clinical pharmaceutical studies. Northwest Kinetics provides a full range of services for both short and long-term Phase I and II trials. Our services can include review of protocol design, pharmacokinetic consultation, patient recruitment, study execution, data management and record keeping, and repor...

Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG

Novartis AG

Novartis's name, derived from the Latin novae artes, means "new skills" and reflects Novartis's commitment to focus research and development to bring new healthcare products to the patients and physicians. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, pr...

Advicenne

Advicenne (Euronext: ADVIC) is a pharmaceutical company developing pediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases. The Company’s lead product is ADV7103 which has demonstrated positive results in a European pivotal phase 3 study in children and adults with distal Tubular Renal Acidosis (dTRA), is also being...

Novartis Vaccines and Diagnostics

Novartis Vaccines is a global leader in providing vaccines to protect against deadly meningococcal disease. Through industry-leading scientific expertise, the company is focused on extending critical meningococcal vaccines research. In addition to developing Menveo vaccine, Novartis Vaccines is developing a recombinant vaccine for its potential to provide broad coverage against multiple strains of...

Corcept Therapeutics

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the development of drugs for the treatment of severe psychiatric and neurological diseases. Our lead product, CORLUX, is currently in three Phase 3 clinical trials for the treatment of the psychotic features of psychotic major depression (PMD), a disorder that affects approximately three million adults in the United States ea...

Clinical Network Services (CNS)

Clinical Network Services (CNS) Pty Ltd is an Australian CRO, focused on providing full contract research organisational clinical trial services to the international healthcare community particularly during the early phase (Phase I and Phase II) clinical development of their products. CNS has established itself as Brisbane’s only headquartered Australian CRO working both nationally with dedicat...

Rigel Pharmaceuticals

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases and cancer, as well as viral and metabolic diseases. Our goal is to file one new investigational new drug (IND) application in a significant indication each year. We have achieved this goal since 2002. Our pioneering research focuses on intracellu...

AmeriTrial

AmeriTrial is a full service Contract Research Organization (CRO) specializing in the following clinical trial services:Phase III-IV Clinical Trials Rx-to-OTC Switch Trials (Actual Use Studies) Post Approval OTC Studies (Actual Use Studies) Medical Device Studies 24/7 Telephonic Medical Response Center We invite you to discover how AmeriTrial can contribute expertise, innovation and value-added ...

Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 300 organizations and regulatory agencies worldwide including: AstraZeneca, Bost...

Phase Forward Incorporated

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 300 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Sc...

BioAdvice

BioAdvice conducts in vivo preclinical studies from the screening phase till proof of concept studies.BioAdvice have extensive experience with: Biopharmaceuticals. Biomaterials. Devices. Conventional pharmaceuticals.


More From BioPortfolio on "Novartis Reports Positive Results From Ofatumumab Phase Studies"

Quick Search

Corporate Database Quicklinks